Search Login Register

Infarction Summary

Description: Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.

Also Known As: Infarctions

Networked: 11762 relevant articles (601 outcomes, 1166 trials/studies) for this Disease

Key Drugs and Agents for Infarction

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. glucuronyl glucosamine glycan sulfate (Vessel) : 16 outcomes 21 studies in 573 results : IBA
  2. Heparin (Liquaemin) : 12 outcomes 12 studies in 120 results : FDA 74 Generic
  3. Nitroglycerin (Dynamite) : 10 outcomes 11 studies in 55 results : FDA 53 Generic
  4. Verapamil (Calan) : 9 outcomes 48 studies in 85 results : FDA 64 Generic
  5. Aspirin (Acetylsalicylic Acid) : 9 outcomes 39 studies in 172 results : FDA 80 Generic
  6. Streptokinase : 9 outcomes 25 studies in 121 results : FDA 1
  7. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors) : 9 outcomes 18 studies in 70 results : IBA
  8. Diltiazem (Cardizem) : 8 outcomes 23 studies in 62 results : FDA 50 Generic
  9. Calcium : 8 outcomes 15 studies in 110 results : IBA
  10. Adenosine : 8 outcomes 9 studies in 57 results : FDA 19 Generic
Show All >>

Diseases Related to Infarction

  1. Myocardial Infarction
  2. Ischemia
  3. Heart Failure
  4. Stroke (Strokes)
  5. Brain Ischemia (Cerebral Ischemia)
Show All >>

Key Therapies for Infarction

Efficacy Chart >>
  1. Angioplasty (Angioplasty, Transluminal) : 20 outcomes 34 studies in 345 results
  2. Transplantation (Transplant Recipients) : 16 outcomes 11 studies in 140 results
  3. Thrombolytic Therapy : 14 outcomes 23 studies in 242 results
  4. Ligation : 9 outcomes 13 studies in 298 results
  5. Decompressive Craniectomy : 7 outcomes 6 studies in 56 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.